[A crossed pharmacokinetic assay of two presentations of HRZ: one with combined components and one with isolated components H+R+Z].
Khaled
S
S
Hamadi
A
A
Boulahbal
F
F
Chaulet
P
P
D000284:Administration, Oral; D000328:Adult; D004338:Drug Combinations / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012293:Rifampin / Q000008:administration & dosage / Q000493:pharmacokinetics*
D004338:Drug Combinations; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin
Etude pharmacocinétique en essai croisé de deux présentations de l'association HRZ: l'une en comprimé combiné, l'autre en comprimés isolés H + R + Z.